Mineralys Therapeutics, Inc. (MLYS) Misses Q3 EPS by 42c
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Join SI Premium – FREE
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q3 EPS of ($1.13), $0.42 worse than the analyst estimate of ($0.71).
For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PayPal on watch amid layoffs rumors
- FTC reportedly suing Amazon over ad practices, shares fall
- Titan Machinery (TITN) 2K contracts of September 22.50 calls trade, share price up 17%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
